Virpax Pharmaceuticals, Inc.
VRPXDelisted Jul 21, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708331
Virpax Pharmaceuticals, Inc. was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Jul 10, 2024; 7 institutions reported holding it in 13F filings for Q1 2025, worth $34.9K in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Virpax Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −2 vs. Q4 2021
- Shares held
- 2.49M
- +250.6K (+11.2%) vs. Q4 2021
- Total value
- $3.29M
- −$4.38M (−57.1%) vs. Q4 2021
- New holders
- 5
- 6 more added
- Sold out
- 7
- 1 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 1 | $2 |
| Q1 2025 | 7 | $34.9K |
| Q4 2024 | 12 | $46.7K |
| Q3 2024 | 9 | $66.8K |
| Q2 2024 | 8 | $12.6K |
| Q1 2024 | 6 | $6.44K |
| Q4 2023 | 18 | $120.5K |
| Q3 2023 | 13 | $493.4K |
| Q2 2023 | 14 | $827.7K |
| Q1 2023 | 17 | $873.8K |
| Q4 2022 | 21 | $973.0K |
| Q3 2022 | 16 | $2.17M |
| Q2 2022 | 16 | $3.13M |
| Q1 2022 | 16 | $3.29M |
| Q4 2021 | 18 | $7.67M |
| Q3 2021 | 13 | $11.4M |
| Q2 2021 | 7 | $1.12M |
| Q1 2021 | 5 | $1.29M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Virpax Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 53 | $0 | 0.00% | +1+1.9% | Added |
| Advisor Group Holdings, Inc. | 160 | $0 | 0.00% | +110+220.0% | Added |
| Hantz Financial Services, Inc. | 100 | $0 | 0.00% | +100 | New |
| BlackRock Inc. | 464 | $1.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,689 | $6.00K | 0.00% | +2,689 | New |
| Citigroup Inc | 12,179 | $27.0K | 0.00% | +12,179 | New |
| Northern Trust Corp | 15,221 | $34.0K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 17,170 | $38.0K | 0.00% | −600−3.4% | Reduced |
| Warberg Asset Management LLC | 17,710 | $39.0K | 0.01% | +17,710 | New |
| The PNC Financial Services Group, Inc. | 25,125 | $56.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 63,013 | $139.0K | 0.00% | +15,342+32.2% | Added |
| Morgan Stanley | 78,511 | $174.0K | 0.00% | +73,619+1,504.9% | Added |
| Renaissance Technologies LLC | 156,600 | $348.0K | 0.00% | +156,600 | New |
| Vanguard Group Inc | 341,977 | $759.0K | 0.00% | +14,672+4.5% | Added |
| Kepos Capital LP | 750,000 | $1.67M | 0.12% | 00.0% | Unchanged |
| Sabby Management, LLC | 1,005,156 | – | – | +128,322+14.6% | Added |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −98,046−100.0% | Sold out |
| Quantum Private Wealth, LLC | 0 | $0 | 0.00% | −22,500−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,279−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −11,790−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −11,385−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,537−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −643−100.0% | Sold out |